Nigel Ten Fleming PhD

Dr. Nigel is a serial entrepreneur with 25 years experience in biotechology and business development. He brings sector experience in healthcare diagnostics and pharma and experience in board development, fund raising, and company valuation. He was founder and chairman of Athena Diagnostics a neurological diagnostics company which recently was valued at $740m, serves on the board of Impax Laboratories (ipxl) a publically traded pharmaceutical company). His other experience includes being a lecturer at Harvard medical school and has served as Ceo, Board Chair, and Advisor to numerous young biotechnology companies. Nigel holds a PhD from Cambridge University and completed his post doc at Harvard University. He recently relocated from San Francisco to Catalonia, where he currently lives and works.